Neena M Patil's Insider Trades & SAST Disclosures
Neena M Patil's most recent trade in Teleflex Incorporated was a trade of 2,226 Stock Option / (Right to Buy) done . Disclosure was reported to the exchange on May 9, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Neena M Patil.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 2,226 | 2,226 | - | - | Stock Option / (Right to Buy) | |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 1,051 | 2,626 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Sale or transfer of securities back to the company at price $ 138.95 per share. | 05 Mar 2025 | 4,088 | 47,526 (0%) | 0% | 139.0 | 568,028 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 12,518 | 45,836 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 5,778 | 51,614 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 144.87 per share. | 27 Feb 2025 | 3,800 | 33,318 (0%) | 0% | 144.9 | 550,506 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 5,864 | 39,023 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.62 per share. | 17 Jan 2025 | 1,905 | 37,118 (0%) | 0% | 122.6 | 233,591 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 123.41 per share. | 08 Nov 2024 | 3,700 | 33,048 (0%) | 0% | 123.4 | 456,617 | Ordinary Shares |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 1,349 | 1,349 | - | - | Stock Option / (Right to Buy) | |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 649 | 1,575 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 109.65 per share. | 03 May 2024 | 5,000 | 36,629 (0%) | 0% | 109.7 | 548,250 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.53 per share. | 05 Mar 2024 | 3,432 | 41,629 (0%) | 0% | 117.5 | 403,363 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 12,348 | 45,061 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Neena Patil M. | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 5,087 | 34,369 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Patil Neena M. | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 119.13 per share. | 17 Jan 2024 | 1,656 | 32,713 (0%) | 0% | 119.1 | 197,279 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 139.59 per share. | 15 Aug 2023 | 750 | 30,686 (0%) | 0% | 139.6 | 104,695 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Sale or transfer of securities back to the company at price $ 131.51 per share. | 07 Aug 2023 | 1,390 | 31,436 (0%) | 0% | 131.5 | 182,799 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 127.98 per share. | 01 Jun 2023 | 1,526 | 32,900 (0%) | 0% | 128.0 | 195,290 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 128.01 per share. | 01 Jun 2023 | 74 | 32,826 (0%) | 0% | 128.0 | 9,473 | Ordinary Shares |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 1,076 | 1,076 | - | - | Stock Option / (Right to Buy) | |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 527 | 926 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 9,419 | 36,262 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.78 per share. | 03 Mar 2023 | 1,923 | 34,339 (0%) | 0% | 142.8 | 274,566 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 142.34 per share. | 16 Nov 2022 | 3,510 | 26,769 (0%) | 0% | 142.3 | 499,613 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | EVP and Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 153.72 per share. | 05 Aug 2022 | 1,321 | 30,279 (0%) | 0% | 153.7 | 203,064 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | Chief Legal Officer (CLO) | Sale of securities on an exchange or to another person at price $ 152.15 per share. | 10 May 2022 | 1,000 | 31,600 (0%) | 0% | 152.2 | 152,150 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | Chief Legal Officer (CLO) | Gift of securities by or to the insider at price $ 0.00 per share. | 10 May 2022 | 161 | 32,516 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Neena M. Patil | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 153.92 per share. | 06 May 2022 | 296 | 32,677 (0%) | 0% | 153.9 | 45,559 | Ordinary Shares |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 1,937 | 1,937 | - | - | Stock Option / (Right to Buy) | |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 399 | 399 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Neena M. Patil | Chief Legal Officer (CLO) and | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 8,886 | 34,201 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Neena M. Patil | Chief Legal Officer (CLO) and | Payment of exercise price or tax liability using portion of securities received from the company at price $ 153.96 per share. | 03 Mar 2022 | 1,228 | 32,973 (0%) | 0% | 154.0 | 189,063 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | CLO&SVP Legal and Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 148.49 per share. | 05 Aug 2021 | 993 | 25,233 (0%) | 0% | 148.5 | 147,451 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 164.75 per share. | 05 Mar 2021 | 691 | 26,147 (0%) | 0% | 164.7 | 113,842 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Neena M. Patil | Chief Legal Officer (CLO) and | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 7,270 | 26,838 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Neena M. Patil | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.24 per share. | 05 Aug 2020 | 987 | 19,489 (0%) | 0% | 122.2 | 120,651 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges